Publications

Found 1 results
Filters: Author is X.-Q. Dong  [Clear All Filters]
2012
X. - Q. Dong, Du, Q., Yu, W. - H., Zhang, Z. - Y., Zhu, Q., Che, Z. - H., Wang, H., Chen, J., Yang, S. - B., and Wen, J. - F., Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with C-reactive protein in Chinese Han patients with spontaneous basal ganglia hemorrhage, vol. 11, pp. 1841-1850, 2012.
Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, et al. (2005). Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc. Diabetol. 4: 10. http://dx.doi.org/10.1186/1475-2840-4-10 PMid:15998471 PMCid:1183229   Bokarewa M, Nagaev I, Dahlberg L, Smith U, et al. (2005). Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174: 5789-5795. PMid:15843582   Brown R, Thompson HJ, Imran SA, Ur E, et al. (2008). Traumatic brain injury induces adipokine gene expression in rat brain. Neurosci. Lett. 432: 73-78. http://dx.doi.org/10.1016/j.neulet.2007.12.008 PMid:18178314 PMCid:2367125   Cho YM, Youn BS, Chung SS, Kim KW, et al. (2004). Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47: 559-565. PMid:14740159   Dong XQ, Hu YY, Yu WH and Zhang ZY (2010a). High concentrations of resistin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. J. Crit. Care 25: 243-247. http://dx.doi.org/10.1016/j.jcrc.2009.09.008 PMid:19903588   Dong XQ, Yang SB, Zhu FL, Lv QW, et al. (2010b). Resistin is associated with mortality in patients with traumatic brain injury. Crit. Care 14: R190. http://dx.doi.org/10.1186/cc9307 PMid:21029428 PMCid:3219297   Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, et al. (2007). Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin. Chim. Acta 378: 78-85. http://dx.doi.org/10.1016/j.cca.2006.10.023 PMid:17173885   Fasshauer M, Klein J, Neumann S, Eszlinger M, et al. (2001). Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 288: 1027-1031. http://dx.doi.org/10.1006/bbrc.2001.5874 PMid:11689013   Hivert MF, Manning AK, McAteer JB, Dupuis J, et al. (2009). Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes 58: 750-756. http://dx.doi.org/10.2337/db08-1339 PMid:19074981 PMCid:2646076   Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, et al. (2003). Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 309: 286-290. http://dx.doi.org/10.1016/j.bbrc.2003.07.003 PMid:12951047   Kawanami D, Maemura K, Takeda N, Harada T, et al. (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun. 314: 415-419. http://dx.doi.org/10.1016/j.bbrc.2003.12.104 PMid:14733921   Kothari RU, Brott T, Broderick JP, Barsan WG, et al. (1996). The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27: 1304-1305. http://dx.doi.org/10.1161/01.STR.27.8.1304 PMid:8711791   Lin XJ, Zhang YD, Guan QS, Di Q, et al. (2007). Plasma resistin levels and single-nucleotide polymorphisms in resistin gene 5' flanking region in patients with stroke. Chin. Med. Sci. J. 22: 27-32. PMid:17441314   Lu SC, Shieh WY, Chen CY, Hsu SC, et al. (2002). Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 530: 158-162. http://dx.doi.org/10.1016/S0014-5793(02)03450-6   Osawa H, Yamada K, Onuma H, Murakami A, et al. (2004). The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am. J. Hum. Genet. 75: 678-686. http://dx.doi.org/10.1086/424761 PMid:15338456 PMCid:1182055   Osawa H, Tabara Y, Kawamoto R, Ohashi J, et al. (2007). Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 30: 1501-1506. http://dx.doi.org/10.2337/dc06-1936 PMid:17384338   Pang SS and Le YY (2006). Role of resistin in inflammation and inflammation-related diseases. Cell. Mol. Immunol. 3: 29-34. PMid:16549046   Piestrzeniewicz K, Luczak K and Goch JH (2009). Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men. Cardiol. J. 16: 36-42. PMid:19130414   Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, et al. (2005). Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932-939. http://dx.doi.org/10.1161/01.CIR.0000155620.10387.43 PMid:15710760   Shetty GK, Economides PA, Horton ES, Mantzoros CS, et al. (2004). Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27: 2450-2457. http://dx.doi.org/10.2337/diacare.27.10.2450 PMid:15451915   Silswal N, Singh AK, Aruna B, Mukhopadhyay S, et al. (2005). Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 334: 1092-1101. http://dx.doi.org/10.1016/j.bbrc.2005.06.202 PMid:16039994   Steppan CM, Bailey ST, Bhat S, Brown EJ, et al. (2001a). The hormone resistin links obesity to diabetes. Nature 409: 307-312. http://dx.doi.org/10.1038/35053000 PMid:11201732   Steppan CM, Brown EJ, Wright CM, Bhat S, et al. (2001b). A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. U. S. A. 98: 502-506. http://dx.doi.org/10.1073/pnas.98.2.502 PMid:11209052 PMCid:14616   Tsukahara T, Nakashima E, Watarai A, Hamada Y, et al. (2009). Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res. Clin. Pract. 84: 179-186. http://dx.doi.org/10.1016/j.diabres.2008.10.021 PMid:19269054   Ukkola O, Kunnari A and Kesaniemi YA (2008). Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul. Pept. 149: 56-59. http://dx.doi.org/10.1016/j.regpep.2007.08.025 PMid:18440081   Wiesner G, Brown RE, Robertson GS, Imran SA, et al. (2006). Increased expression of the adipokine genes resistin and fasting-induced adipose factor in hypoxic/ischaemic mouse brain. Neuroreport 17: 1195-1198. http://dx.doi.org/10.1097/01.wnr.0000224776.12647.ba PMid:16837853   Wilkinson M, Brown R, Imran SA and Ur E (2007). Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 86: 191-209. http://dx.doi.org/10.1159/000108635 PMid:17878708   Yoshino T, Kusunoki N, Tanaka N, Kaneko K, et al. (2011). Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern. Med. 50: 269-275. http://dx.doi.org/10.2169/internalmedicine.50.4306 PMid:21325757